Clinical Trial Update: Blood Coagulation Parameters in Patients Receiving Intravitreal Aflibercept for Age-related Macular Degeneration [NA]

View source ↗

Summary

This clinical trial update reports the completion of a study investigating blood coagulation parameters in patients receiving intravitreal aflibercept for neova…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

Sponsor: University Hospital of Patras | Conditions: Neovascular Age-related Macular Degeneration | NA | Status: COMPLETED